282 LEE HY et al. comes, 15 recently published hypertension guidelines state that diuretics,
β-blockers, calcium antagonists, angiotensin-converting enzyme inhibitors (ACEIs) and …

Statins effectively reduce cardiovascular disease (CVD) morbidity and mortality. However,
even after low-density lipoprotein cholesterol goal attainment there is a residual CVD risk …

Background: Statins, a class of lipid lowering drugs, decrease mortality associated with
cardiovascular events. As hypercholesterolemia is often accompanied by hypertension, a …

The renin-angiotensin system (RAS) and dyslipidaemia have been shown to be involved in
the genesis and progression of atherosclerosis. Manipulation of the RAS has been effective …

Introduction High blood pressure (BP) affects over 40% of adults over the age of 25
worldwide and is the leading global risk factor for death or disability. Hypertension is also …

Statins and renin-angiotensin system (RAS) inhibitors are 2 classes of drugs prescribed
frequently in clinical practice that may have pleiotropic effects in addition to cholesterol …

Hypercholesterolemia and hypertension are the most common risk factors for cardiovascular
disease (CVD). Updated guidelines emphasize target reduction of overall cardiovascular …

The Statins in Preventive Cardiology | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

RESULTS—Fluvastatin. simvastatin, lovastatin, atorvastatin, and cerivastatin, but not
pravastatin, dose—dependently decrease smooth muscle cell (SMC) migration and …

Hypertension increases the risk of type 2 diabetes mellitus (T2DM) and cardiovascular
disease. In addition to lowering blood pressure, blockade of the renin–angiotensin …